VKTX - Viking Therapeutics, Inc.
31.51
-0.630 -1.999%
Share volume: 3,139,422
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$32.14
-0.63
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-25-2024 | 07-24-2024 | 10-23-2024 | 02-26-2025 | 04-24-2025 | 07-23-2025 | 10-22-2025 | 02-11-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 34.073 M | 34.054 M | 36.556 M | 46.238 M | 55.469 M | 74.574 M | 98.561 M | 164.738 M | |
| Selling general and admin | 9.970 M | 10.285 M | 13.771 M | 15.251 M | 14.078 M | 14.421 M | 8.608 M | 11.280 M | |
| Research and development | 24.103 M | 23.769 M | 22.785 M | 30.987 M | 41.391 M | 60.153 M | 89.953 M | 153.458 M | |
| Total expenses | 34.101 M | 34.054 M | 36.580 M | 46.280 M | 55.493 M | 74.598 M | 98.561 M | 164.746 M | |
| -0.14% | 7.42% | 26.52% | 19.91% | 34.43% | 32.12% | 67.15% | |||
| Operating income | -34.073 M | -34.054 M | -36.556 M | -46.238 M | -55.469 M | -74.574 M | -98.561 M | -164.738 M | |
| Ebit | -34.073 M | -34.070 M | -36.447 M | -46.219 M | -55.469 M | -74.574 M | -98.559 M | -164.738 M | |
| Pretax income | -27.328 M | -22.250 M | -24.916 M | -35.375 M | -45.605 M | -65.541 M | -90.787 M | -157.650 M | |
| -18.58% | 11.98% | 41.98% | 28.92% | 43.71% | 38.52% | 73.65% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -27.356 M | -22.250 M | -24.940 M | -35.417 M | -45.629 M | -65.561 M | -90.787 M | -157.662 M | |
| 18.67% | -12.09% | -42.01% | -28.83% | -43.68% | -38.48% | -73.66% |